⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6236107 | 0.90 | — | — | |
| SCHEMBL15058220 | 0.90 | — | — | |
| SCHEMBL8763241 | 0.85 | — | — | |
| SCHEMBL9478548 | 0.82 | — | — | |
| SCHEMBL128356 | 0.82 | — | — | |
| SCHEMBL27735539 | 0.79 | — | — | |
| SCHEMBL3629035 | 0.78 | — | — | |
| SCHEMBL6920148 | 0.78 | — | — | |
| SCHEMBL2757919 | 0.78 | — | — | |
| SCHEMBL5394629 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1469842-A4 | BICYCLIC CB2 CANNABINOID RECEPTOR LIGANDS | PHARMOS CORP (US) | 2006-04-26 | — | — | EP | claimed |
| JP-2005523259-A | — | — | 2005-08-04 | — | — | JP | claimed |
| EP-1469842-A2 | BICYCLIC CB2 CANNABINOID RECEPTOR LIGANDS | PHARMOS CORPORATION (US) | 2004-10-27 | — | — | EP | claimed |
| WO-2003063758-A2 | BICYCLIC CB2 CANNABINOID RECEPTOR LIGANDS | PHARMOS CORPORATION (US) | 2003-08-07 | — | — | WO | claimed |
| EP-1192141-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES AS NEUROPROTECTIVE AGENTS | AstraZeneca UK Limited (GB) | 2002-04-03 | — | — | EP | claimed |
| EP-1140863-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES USEFUL IN THE TREATMENT OF NEUROLOGICAL DISORDERS | AstraZeneca AB (SE) | 2001-10-10 | — | — | EP | claimed |
| WO-2000078736-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES AS NEUROPROTECTIVE AGENTS | ASTRAZENECA UK LIMITED (GB) | 2000-12-28 | — | — | WO | claimed |
| WO-2000039105-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES USEFUL IN THE TREATMENT OF NEUROLOGICAL DISORDERS | ASTRAZENECA AB (SE) | 2000-07-06 | — | — | WO | claimed |
| EP-1469842-A4 | BICYCLIC CB2 CANNABINOID RECEPTOR LIGANDS | PHARMOS CORP (US) | 2006-04-26 | — | — | EP | disclosed |
| EP-1469842-A2 | BICYCLIC CB2 CANNABINOID RECEPTOR LIGANDS | PHARMOS CORPORATION (US) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003063758-A2 | BICYCLIC CB2 CANNABINOID RECEPTOR LIGANDS | PHARMOS CORPORATION (US) | 2003-08-07 | — | — | WO | disclosed |
| EP-1192141-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES AS NEUROPROTECTIVE AGENTS | AstraZeneca UK Limited (GB) | 2002-04-03 | — | — | EP | disclosed |
| EP-1140863-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES USEFUL IN THE TREATMENT OF NEUROLOGICAL DISORDERS | AstraZeneca AB (SE) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000078736-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES AS NEUROPROTECTIVE AGENTS | ASTRAZENECA UK LIMITED (GB) | 2000-12-28 | — | — | WO | disclosed |
| WO-2000039105-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES USEFUL IN THE TREATMENT OF NEUROLOGICAL DISORDERS | ASTRAZENECA AB (SE) | 2000-07-06 | — | — | WO | disclosed |